Medical News
Stay on top of the latest medical news about blood cancer: Get the latest headlines, supplied by respected and trusted medical sources.
No results were returned. Please try another search term.
About LLS
www.lls.org/aboutllsDid you know?
2001: The FDA approves Gleevec®, a drug developed by LLS-funded researcher Brian Druker, M.D., to treat patients with CML and other blood cancers.
- Mission and Goals
- Research Successes
- Senior Staff
- Board of Directors
- Scientific Advisors
- Clinical Advisors
- Our History
- News
- LLS Blog
- Our Partners
- Our Financial Information
- Careers at LLS
- National Recognition & Awards
- Chapters
- Contact Us
last updated on
Thursday, September 22, 2011
The Leukemia & Lymphoma Society (LLS) is the world's largest voluntary health agency dedicated to blood cancer. The LLS mission: Cure leukemia, lymphoma, Hodgkin's disease and myeloma, and improve the quality of life of patients and their families. LLS funds lifesaving blood cancer research around the world and provides free information and support services.
